| Authors: |
Lettieri CJ; Idorsia Pharmaceuticals US Ltd, Radnor, Pennsylvania, USA.; Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Uniformed Services University, Bethesda, Maryland, USA., Briasoulis O; Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland., Léger D; VIFASOM (Vigilance Fatigue et Santé Publique), Université Paris Cité, Paris, France.; APHP, Hôtel Dieu de Paris, Centre du Sommeil et de la Vigilance, Paris, France., Luyet PP; Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland., Pépin JL; Grenoble Alpes University, Grenoble, France., Quan SF; Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital and Division of Sleep Medicine, Harvard Medical School, Boston, Massachusetts, USA., Raphelson J; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Diego, San Diego, California, USA., Saskin P; Idorsia Pharmaceuticals US Ltd, Radnor, Pennsylvania, USA., Malhotra A; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Diego, San Diego, California, USA. |
